We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Prognostic factors and the impact of new therapies for CLL
Tuesday, January 19, 2016
The availability of new monoclonal antibodies and novel targeted therapies for chronic lymphocytic leukemia has greatly increased the complexity of treating symptomatic patients. Richard Furman, M.D. joins a panel of doctors and researchers in this OncLive video.
